Andere talen United Therapeutics Corporation

Aandelen

UTHR

US91307C1027

Geschatte realtime Cboe BZX Andere beurzen 21:06:14 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
237 ^USD	+0,05%		+1,82%	+7,70%

17/04	Insider bij United Therapeutics verkocht aandelen ter waarde van $1.682.819, volgens een recent SEC-document	MT
15/04	Insider bij United Therapeutics verkocht aandelen ter waarde van $1.707.775, volgens een recent SEC-document	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

United Therapeutics Insider Sold Shares Worth $1,682,819, According to a Recent SEC Filing	17/04
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference	16/04
United Therapeutics Insider Sold Shares Worth $1,707,775, According to a Recent SEC Filing	15/04
United Therapeutics Insider Sold Shares Worth $6,831,737, According to a Recent SEC Filing	11/04
United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing	09/04
United Therapeutics Insider Sold Shares Worth $6,957,709, According to a Recent SEC Filing	05/04
United Therapeutics Insider Sold Shares Worth $1,394,248, According to a Recent SEC Filing	04/04
Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension	01/04
Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling	01/04
United Therapeutics Corporation Announces Extension of Credit Agreement	29/03
United Therapeutics Insider Sold Shares Worth $7,375,339, According to a Recent SEC Filing	27/03
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation	26/03
United Therapeutics Corporation announces an Equity Buyback for $1,000 million worth of its shares.	25/03
United Therapeutics Insider Sold Shares Worth $7,100,981, According to a Recent SEC Filing	25/03
United Therapeutics Authorizes Accelerated $1 Billion Stock Buyback Through Citigroup	25/03
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program	25/03
United Therapeutics Corporation authorizes a Buyback Plan.	24/03
United Therapeutics Insider Sold Shares Worth $1,418,726, According to a Recent SEC Filing	22/03
United Therapeutics Insider Sold Shares Worth $7,088,196, According to a Recent SEC Filing	21/03
The Printed Future Of Transplantology, Or How Science Fiction Became Reality	19/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen United Therapeutics Corporation

Aandelen

UTHR

US91307C1027

Andere talen

Filters